NDC 73070-400 – Insulin Degludec

Insulin Degludec 100 U/mL · Injection, Solution · Subcutaneous

Human Prescription Drug

Product NDC73070-400

Product details

Brand name
Insulin Degludec
Generic name
Insulin degludec
Labeler
Novo Nordisk Pharma, Inc.
Dosage form
Injection, Solution
Route
Subcutaneous
Marketing category
BLA · BLA203314
Marketed since
July 1, 2022
Marketing end
August 31, 2027
Pharmacologic class
Insulin Analog

Active ingredients

Uses, dosage, side effects and warnings for Insulin Degludec →

Package NDC codes (1)

Package NDCDescriptionSince
73070-400-111 VIAL, GLASS in 1 CARTON (73070-400-11) / 10 mL in 1 VIAL, GLASSJul 1, 2022

Other Insulin Degludec products